Erenumab (Anti-CALCRL / CGRPR)

Ask supplier a question | View on supplier's website

Erenumab (Anti-CALCRL/CGRPR) is a fully human monoclonal antibody targeting CGRP receptor (calcitonin gene–related peptide receptor). Erenumab can be used for the prevention of episodic migraine. MW:145.5 KD.

Supplier	Selleck Chemicals
Product #	A2576
Sku #	A2576-1mg*5
Pricing	1mg*5, $790.00

Feedback